Cargando…

Cartilage Protective and Chondrogenic Capacity of WIN-34B, a New Herbal Agent, in the Collagenase-Induced Osteoarthritis Rabbit Model and in Progenitor Cells from Subchondral Bone

We sought to determine the cartilage repair capacity of WIN-34B in the collagenase-induced osteoarthritis rabbit model and in progenitor cells from subchondral bone. The cartilage protective effect of WIN-34B was measured by clinical and histological scores, cartilage area, and proteoglycan and coll...

Descripción completa

Detalles Bibliográficos
Autores principales: Huh, Jeong-Eun, Park, Yeon-Cheol, Seo, Byung-Kwan, Lee, Jae-Dong, Baek, Yong-Hyeon, Choi, Do-Young, Park, Dong-Suk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747396/
https://www.ncbi.nlm.nih.gov/pubmed/23983790
http://dx.doi.org/10.1155/2013/527561
_version_ 1782280925756784640
author Huh, Jeong-Eun
Park, Yeon-Cheol
Seo, Byung-Kwan
Lee, Jae-Dong
Baek, Yong-Hyeon
Choi, Do-Young
Park, Dong-Suk
author_facet Huh, Jeong-Eun
Park, Yeon-Cheol
Seo, Byung-Kwan
Lee, Jae-Dong
Baek, Yong-Hyeon
Choi, Do-Young
Park, Dong-Suk
author_sort Huh, Jeong-Eun
collection PubMed
description We sought to determine the cartilage repair capacity of WIN-34B in the collagenase-induced osteoarthritis rabbit model and in progenitor cells from subchondral bone. The cartilage protective effect of WIN-34B was measured by clinical and histological scores, cartilage area, and proteoglycan and collagen contents in the collagenase-induced osteoarthritis rabbit model. The efficacy of chondrogenic differentiation of WIN-34B was assessed by expression of CD105, CD73, type II collagen, and aggrecan in vivo and was analyzed by the surface markers of progenitor cells, the mRNA levels of chondrogenic marker genes, and the level of proteoglycan, GAG, and type II collagen in vitro. Oral administration of WIN-34B significantly increased cartilage area, and this was associated with the recovery of proteoglycan and collagen content. Moreover, WIN-34B at 200 mg/kg significantly increased the expression of CD105, CD73, type II collagen, and aggrecan compared to the vehicle group. WIN-34B markedly enhanced the chondrogenic differentiation of CD105 and type II collagen in the progenitor cells from subchondral bone. Also, we confirmed that treatment with WIN-34B strongly increased the number of SH-2(CD105) cells and expression type II collagen in subchondral progenitor cells. Moreover, WIN-34B significantly increased proteoglycan, as measured by alcian blue staining; the mRNA level of type II α1 collagen, cartilage link protein, and aggrecan; and the inhibition of cartilage matrix molecules, such as GAG and type II collagen, in IL-1β-treated progenitor cells. These findings suggest that WIN-34B could be a potential candidate for effective anti-osteoarthritic therapy with cartilage repair as well as cartilage protection via enhancement of chondrogenic differentiation in the collagenase-induced osteoarthritis rabbit model and progenitor cells from subchondral bone.
format Online
Article
Text
id pubmed-3747396
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-37473962013-08-27 Cartilage Protective and Chondrogenic Capacity of WIN-34B, a New Herbal Agent, in the Collagenase-Induced Osteoarthritis Rabbit Model and in Progenitor Cells from Subchondral Bone Huh, Jeong-Eun Park, Yeon-Cheol Seo, Byung-Kwan Lee, Jae-Dong Baek, Yong-Hyeon Choi, Do-Young Park, Dong-Suk Evid Based Complement Alternat Med Research Article We sought to determine the cartilage repair capacity of WIN-34B in the collagenase-induced osteoarthritis rabbit model and in progenitor cells from subchondral bone. The cartilage protective effect of WIN-34B was measured by clinical and histological scores, cartilage area, and proteoglycan and collagen contents in the collagenase-induced osteoarthritis rabbit model. The efficacy of chondrogenic differentiation of WIN-34B was assessed by expression of CD105, CD73, type II collagen, and aggrecan in vivo and was analyzed by the surface markers of progenitor cells, the mRNA levels of chondrogenic marker genes, and the level of proteoglycan, GAG, and type II collagen in vitro. Oral administration of WIN-34B significantly increased cartilage area, and this was associated with the recovery of proteoglycan and collagen content. Moreover, WIN-34B at 200 mg/kg significantly increased the expression of CD105, CD73, type II collagen, and aggrecan compared to the vehicle group. WIN-34B markedly enhanced the chondrogenic differentiation of CD105 and type II collagen in the progenitor cells from subchondral bone. Also, we confirmed that treatment with WIN-34B strongly increased the number of SH-2(CD105) cells and expression type II collagen in subchondral progenitor cells. Moreover, WIN-34B significantly increased proteoglycan, as measured by alcian blue staining; the mRNA level of type II α1 collagen, cartilage link protein, and aggrecan; and the inhibition of cartilage matrix molecules, such as GAG and type II collagen, in IL-1β-treated progenitor cells. These findings suggest that WIN-34B could be a potential candidate for effective anti-osteoarthritic therapy with cartilage repair as well as cartilage protection via enhancement of chondrogenic differentiation in the collagenase-induced osteoarthritis rabbit model and progenitor cells from subchondral bone. Hindawi Publishing Corporation 2013 2013-08-01 /pmc/articles/PMC3747396/ /pubmed/23983790 http://dx.doi.org/10.1155/2013/527561 Text en Copyright © 2013 Jeong-Eun Huh et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Huh, Jeong-Eun
Park, Yeon-Cheol
Seo, Byung-Kwan
Lee, Jae-Dong
Baek, Yong-Hyeon
Choi, Do-Young
Park, Dong-Suk
Cartilage Protective and Chondrogenic Capacity of WIN-34B, a New Herbal Agent, in the Collagenase-Induced Osteoarthritis Rabbit Model and in Progenitor Cells from Subchondral Bone
title Cartilage Protective and Chondrogenic Capacity of WIN-34B, a New Herbal Agent, in the Collagenase-Induced Osteoarthritis Rabbit Model and in Progenitor Cells from Subchondral Bone
title_full Cartilage Protective and Chondrogenic Capacity of WIN-34B, a New Herbal Agent, in the Collagenase-Induced Osteoarthritis Rabbit Model and in Progenitor Cells from Subchondral Bone
title_fullStr Cartilage Protective and Chondrogenic Capacity of WIN-34B, a New Herbal Agent, in the Collagenase-Induced Osteoarthritis Rabbit Model and in Progenitor Cells from Subchondral Bone
title_full_unstemmed Cartilage Protective and Chondrogenic Capacity of WIN-34B, a New Herbal Agent, in the Collagenase-Induced Osteoarthritis Rabbit Model and in Progenitor Cells from Subchondral Bone
title_short Cartilage Protective and Chondrogenic Capacity of WIN-34B, a New Herbal Agent, in the Collagenase-Induced Osteoarthritis Rabbit Model and in Progenitor Cells from Subchondral Bone
title_sort cartilage protective and chondrogenic capacity of win-34b, a new herbal agent, in the collagenase-induced osteoarthritis rabbit model and in progenitor cells from subchondral bone
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747396/
https://www.ncbi.nlm.nih.gov/pubmed/23983790
http://dx.doi.org/10.1155/2013/527561
work_keys_str_mv AT huhjeongeun cartilageprotectiveandchondrogeniccapacityofwin34banewherbalagentinthecollagenaseinducedosteoarthritisrabbitmodelandinprogenitorcellsfromsubchondralbone
AT parkyeoncheol cartilageprotectiveandchondrogeniccapacityofwin34banewherbalagentinthecollagenaseinducedosteoarthritisrabbitmodelandinprogenitorcellsfromsubchondralbone
AT seobyungkwan cartilageprotectiveandchondrogeniccapacityofwin34banewherbalagentinthecollagenaseinducedosteoarthritisrabbitmodelandinprogenitorcellsfromsubchondralbone
AT leejaedong cartilageprotectiveandchondrogeniccapacityofwin34banewherbalagentinthecollagenaseinducedosteoarthritisrabbitmodelandinprogenitorcellsfromsubchondralbone
AT baekyonghyeon cartilageprotectiveandchondrogeniccapacityofwin34banewherbalagentinthecollagenaseinducedosteoarthritisrabbitmodelandinprogenitorcellsfromsubchondralbone
AT choidoyoung cartilageprotectiveandchondrogeniccapacityofwin34banewherbalagentinthecollagenaseinducedosteoarthritisrabbitmodelandinprogenitorcellsfromsubchondralbone
AT parkdongsuk cartilageprotectiveandchondrogeniccapacityofwin34banewherbalagentinthecollagenaseinducedosteoarthritisrabbitmodelandinprogenitorcellsfromsubchondralbone